INS and Hypoglycemia: An in vivo study showed that insulin-loaded PLGA-FA-CS nanocarriers were able to induce hypoglycemia in a sustained manner as compared to subcutaneously administered insulin, following which a spike in hypoglycemia was observed within two hours after administration.